Category Archives: Medical Press Release
Albany, New York, 22 April 2017: The greater interest in medical awareness and for the latest scientific inventions, has contributed to a surge in the medical devices market. Accordingly, the increased demand for improved medical practices seems to be enabling the market to gain momentum for the future. To highlight the sectors market trend and status, Market Research Report Search Engine (MRRSE) has lately included this engaging report titled as “Global Medical Devices Market– Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016-2024”. This synopsis contributes accurate details connected to the medical devices market along with its bright forecast for the period of 2016-2024.
The Blood Viscometer market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.
In India market, the top players include many company. With key sales data like sales (volume) revenue, market share for top players such as
Thermo Fisher Scientific
Bio Fluid Technology
Split by product types/category, covering many types with sales, revenue and market share for each type, such as
A defibrillator device depolarizes a critical part of a heart muscle thereby helping in restoration of normal heart rhythm. If SCA victims receive cardiopulmonary resuscitation (CPR) and defibrillation within 5 to 12 minutes of cardiac arrest, many lives can be saved. Growing incidences of cardiovascular disease and increasing healthcare infrastructure in the Middle East and Africa are the major factors expected to boost the growth in demand for defibrillators in the region. However, despite an excellent market opportunity in the Middle East and Africa, lack of awareness pertaining to operating of a defibrillator during emergency and unfavorable government intervention to install automated external defibrillators (AEDs) in public places are the key restraints for the growth of market in the Middle East and Africa. The Middle East and Africa defibrillators market was valued at USD 209.6 million in 2013 and is expected to reach an estimated value of USD 347.8 million by 2020, growing at a CAGR of 7.6%.
Vast Growth Opportunities in Asia Pacific to Bring in More Investment
Geographically, the global biologics market is segmented into North America, Europe, Latin America, Asia-Pacific, and Middle East and Africa. North America is presently the dominant regional market, holding a share of over 40% in the global market. The region is expected to continue its dominance in terms of revenue contribution to the global market, expected to account for over 40% by 2024 as well.
Global Molecular Diagnostics Market: Segmentation
Based on technology, the molecular diagnostics market has been segmented into six major categories: PCR and real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing and others which includes mass spectrometry etc. These are the major techniques which are used in molecular diagnostics for diagnosis of disease. Likewise, on the basis of application, the global molecular diagnostics market has been segmented into infectious diseases, oncology, blood screening, microbiology, genetic testing and women’s health. Infectious disease testing has been segmented into two major categories, namely, virology and bacteriology. The market segments have been extensively analyzed based on usefulness, adoption, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2015 to 2025. The molecular diagnostics market report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2015 as the base year. A brief patient pool analysis by infectious disease, cancer and cardiovascular disease have also been discussed in the global molecular diagnostics report.
The molecular diagnostic tests uses a number of technologies such as polymerase chain reaction, hybridization (ISH AND FISH), mass spectrometry, transcription mediated amplification (TMA), next generation sequencing, biochips and microfluidics, others which includes nanotechnology and proteomics. The polymerase chain reaction dominated the molecular diagnostics market in Europe accounting for the share of 40.1% in 2014 as the technique is cost-effective way for copying or amplification of small segments of DNA or RNA. However, next generation sequencing segment is expected to register the fastest growth during the forecast period due to its high throughput, speed, flexibility which has ability to generate hundreds of gigabases of data in a single sequencing run.
Snapshot : Interventional Cardiology Devices Market
The global market for interventional cardiology devices is, however, currently subject to an intense level of competition. Market players are locked in a battle to increase sales volumes and are resorting to price cuts in order to achieve this. This practice is followed largely by regional players and globally prominent companies have to follow suit to hold the majority in global market values. This severely reduces the funds available for further research and development of interventional cardiology devices.
The global bladder cancer market is driven by increasing incidence of bladder cancer, leading to drug innovations for treatment and technological advancements. Bladder cancer is more common in adults aged over 50 years. Hence, increasing geriatric population also contributes to market growth. Furthermore, government initiatives, increasing awareness about bladder cancer and the available treatments, and progressive health care services with growing health care expenditure are expected to propel the global market. However, cancer being an asymptomatic disease at initial stage, needs accurate diagnosis at early stage. Inaccurate and unaffordable diagnosis could hamper the growth of the market. Increasing use of generic drugs and growing patent expirations are factors responsible for the sluggish growth of the market.
In addition, the introduction of cloud computing in the healthcare industry has further alleviated real-time communication and exchange of data. Healthcare IT market has been segmented on the basis of its delivery modes, applications, and components. On the basis of application, the world healthcare IT has been further segmented into provider (clinical information technology and non-clinical information technology) and payer, whereas the market by delivery mode has been further classified as web-premises, on-premises, and cloud-premises. The healthcare information technology by component comprises software, hardware, and services.